Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD

被引:3
|
作者
Nag, Niharika [1 ]
Tripathi, Timir [1 ,2 ]
机构
[1] North Eastern Hill Univ, Dept Biochem, Mol & Struct Biophys Lab, Shillong 793022, India
[2] Indira Gandhi Natl Open Univ IGNOU, Reg Directors Office, Reg Ctr Kohima, Kohima 797001, India
来源
ACS CHEMICAL NEUROSCIENCE | 2022年 / 13卷 / 17期
关键词
Nucleocytoplasmic transport; amyotrophic lateral sclerosis; ALS/FTLD; Nup62; proteinopathy; TDP-43; FG-Nups; condensates; NUCLEOCYTOPLASMIC TRANSPORT; DISRUPTS;
D O I
10.1021/acschemneuro.2c00480
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nucleocytoplasmic transport (NCT) is impaired in C9-ALS/FTLD, a common genetically caused form of ALS and FTLD. The NCT is regulated by proteins called FG-nucleoporins (FG-Nups), with domains enriched in phenylalanine-glycine repeats. However, the relationship between FG-Nups and TDP-43, an RBP found to be mislocalized in ALS/FTLD patients, has not been defined. A recent study found that a critical protein, FG-Nup62, is mislocalized both in vivo and in vitro in diseased states. The mislocalized Nup62 was colocalized with TDP-43 in cytoplasmic inclusions and promoted its liquid-to-solid transition. The work highlights the involvement of Nup62 in the pathogenesis of ALS/FTLD and the interaction between Nup62 and TDP-43.
引用
收藏
页码:2544 / 2546
页数:3
相关论文
共 50 条
  • [31] Proteomic analyses of TDP-43 proteinopathy
    Hasegawa, Masato
    Arai, Tetsuaki
    Nonaka, Takashi
    Kametani, Fuyuki
    Yoshida, Mari
    Ikeda, Kenji
    Akiyama, Haruhiko
    NEUROSCIENCE RESEARCH, 2010, 68 : E35 - E35
  • [32] Drosophila models of TDP-43 proteinopathy
    Adachi, Yoshitsugu
    Diaper, Danielle
    Burki, Mubarik
    Hirth, Frank
    JOURNAL OF NEUROGENETICS, 2010, 24 : 60 - 60
  • [33] Fosmn Syndrome: a Tdp-43 proteinopathy?
    Dhawan, P. S.
    Goodman, B. P.
    Toro, C.
    Dyck, P. J. B.
    Giannini, C.
    Bosch, E. P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E332 - E332
  • [34] Transthyretin attenuates TDP-43 proteinopathy by autophagy activation via ATF4 in FTLD-TDP
    Chu, Yuan-Ping
    Jin, Lee-Way
    Wang, Liang-Chao
    Ho, Pei-Chuan
    Wei, Wei-Yen
    Tsai, Kuen-Jer
    BRAIN, 2023, 146 (05) : 2089 - 2106
  • [35] Behavioral changes on amyotrophic lateral sclerosis (ALS): a case of ALS/FTD TDP-43 proteinopathy
    dos Santos, Bruno Lopes
    Rodrigues, Guilherme Riccioppo
    Tumas, Vitor
    Homem Pittella, Jose Eymard
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (03) : 232 - 233
  • [36] Retinal Degeneration in FTLD Patients and PGRN-Deficient Mice Preceded by TDP-43 Mislocalization
    Ward, Michael E.
    Taubes, Alice
    Miller, Bruce L.
    Gelfand, Jeffrey M.
    Gan, Li
    Green, Ari J.
    ANNALS OF NEUROLOGY, 2012, 72 : S42 - S43
  • [37] Multiple system atrophy is not a TDP-43 proteinopathy
    Geser, F.
    Malunda, J.
    Wenning, G. K.
    Lee, V. M. -Y.
    Trojanowksi, J. Q.
    MOVEMENT DISORDERS, 2009, 24 : S426 - S427
  • [38] TDP-43 Proteinopathy in Chronic Traumatic Encephalopathy
    Mckee, Ann
    Gavett, Brandon
    Stern, Robert
    Nowinski, Christopher
    Cantu, Robert
    Sullivan, Chris
    Perl, Daniel
    Hedley-Whyte, E. Tessa
    Daneshvar, Daniel
    Kowall, Neil
    Budson, Andrew
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 552 - 552
  • [39] Propagation of TDP-43 proteinopathy in neurodegenerative disorders
    Keszycki, Rachel
    Jamshidi, Pouya
    Kawles, Allegra
    Minogue, Grace
    Flanagan, Margaret E.
    Zaccard, Colleen R.
    Mesulam, M-Marsel
    Gefen, Tamar
    Geula, Changiz
    NEURAL REGENERATION RESEARCH, 2022, 17 (07) : 1498 - 1500
  • [40] The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
    Ito Kawakami
    Tetsuaki Arai
    Masato Hasegawa
    Acta Neuropathologica, 2019, 138 : 751 - 770